Last reviewed · How we verify

NCT06288789

Turkish Validity and Reliability of the Social Frailty Index

Completed NA Last updated 25 April 2024
What this trial tests

NA trial testing Social Frailty Index in Elderly in 186 participants. Completed in 30 March 2024.

Timeline
25 February 2024
Primary endpoint
20 March 2024
30 March 2024

Quick facts

Lead sponsorPamukkale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment186
Start date25 February 2024
Primary completion20 March 2024
Estimated completion30 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

65 and older, any sex, with Elderly or Frailty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim was to examine the validity and reliability of the Social Frailty Index in Turkish among older adults. 65 years and above older adults will be included included in the study. Older adults who agree to participate in the study will first be administered the Hodkinson Mental Test. Those who score 6 points and above will be included in the study. To evaluate the validity of the \"Social Frailty Index\", Social Inclusion Scale, Older people\'s quality of life-brief (OPQOL-brief) and Lubben Social Network Scale will be applied to the participants. To determine the reliability of the \"Social Frailty Index\", older adults who do not receive any treatment will be tested and re-tested at one-week intervals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The validity of Turkish version of Social Frailty Index in older adults: An index of social attributes predictive of mortality.
    Gur Kabul E, Aksoy CC, Basakci Calik B. · · 2025 · PMID 39426188 · DOI 10.1016/j.regg.2024.101556

Verify or expand the search:

Other recruiting trials for Elderly

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06288789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing